Indian-origin NASA astronaut Anil Menon launches to ISS on July 14

On July 14, a Soyuz spacecraft will lift off from the Baikonur cosmodrome in Kazakhstan carrying three people toward the International Space Station. One of them is Anil Menon, a 49-year-old emergency medicine physician and US Space Force colonel who was born in Minneapolis to Ukrainian and Indian immigrant parents. He will spend eight months in orbit, conducting research that could reshape how humans survive and work in deep space.

Menon's path to this launch reads like a deliberate accumulation of expertise across domains that rarely intersect. After his Air Force service, which included frontline deployment in Afghanistan during Operation Enduring Freedom, he pivoted toward humanitarian medicine. He worked with the Himalayan Rescue Association, providing medical care to climbers on Mount Everest—a choice that placed him at the edge of human endurance in a different way. He also spent a year in India as a Rotary Ambassadorial Scholar, supporting polio vaccination campaigns. These experiences shaped how he thinks about medicine in extreme environments, where resources are scarce and improvisation matters.

His entry into space work came through NASA in 2014, when he joined as a flight surgeon supporting astronauts already on the ISS. In 2018, he moved to SpaceX, where he built the company's medical program from the ground up, helped prepare for the first crewed commercial spaceflights, and contributed to Starship development. NASA selected him as an astronaut in December 2021. His wife, Anna Wilhelm, is also an astronaut; she flew to space in September 2024 on the Polaris Dawn mission. They represent a rare pairing in the astronaut corps—two people from the same household trained for orbital flight.

The research Menon will conduct during his eight-month stay addresses a fundamental problem of long-duration spaceflight: the human body changes in ways that could threaten missions to the Moon, Mars, or beyond. He will study how microgravity alters blood flow, vein structure, and blood composition. These are not abstract measurements. Understanding these shifts is essential for keeping astronauts healthy during months or years away from Earth. He will also test a technology to produce intravenous fluids using the station's potable water system—a capability that becomes critical on deep-space missions where resupply from Earth is impossible or prohibitively expensive. If the system works, future crews heading to Mars or lunar bases could manufacture their own medical supplies rather than carrying them from home.

Menon will continue work on semiconductor crystal growth in microgravity, research that supports high-performance computing and artificial intelligence applications. He will also perform ultrasound investigations using augmented reality and AI methods, exploring whether machines and algorithms can reduce the need for real-time medical guidance from Earth. On a mission to Mars, communication delays alone make Earth-based medical support impractical. Astronauts will need to diagnose and treat themselves. The technologies Menon tests on the ISS are building blocks for that autonomy.

He will fly alongside cosmonauts Pyotr Dubrov and Anna Kikina, continuing the tradition of international cooperation that has defined the ISS since its first module launched in 1998. The mission represents both continuity and change—the same orbiting laboratory where humans have lived and worked for over two decades, but now hosting research explicitly designed to enable the next phase of exploration, where Earth is no longer within reach for emergency help.